Novel role of Pin1 induction in type II collagen-mediated rheumatoid arthritis

Journal of Immunology

Volumn 183, Issue 10, 2009, Pages 6689-6697

  Jeong, Hye Gwang ^a,b   Pokharel, Yuba Raj ^a   Lim, Sung Chul ^a   Hwang, Yong Pil ^a   Han, Eun Hee ^a   Yoon, Jung Hoon ^a   Ahn, Sang Gun ^a   Lee, Kwang Yeol ^c   Kang, Keon Wook ^a  

^a Chosun University   (South Korea)

^b Chungnam National University   (South Korea)

^c Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; COLLAGEN TYPE 2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; JUGLONE; PEPTIDYLPROLYL ISOMERASE PIN1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANKLE; ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; GENE INDUCTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION INITIATION;

ANIMALS; ANKLE JOINT; ARTHRITIS, RHEUMATOID; CELL LINE; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLOOXYGENASE 2; GENES, REPORTER; HUMANS; INTERLEUKIN-1BETA; MICE; NAPHTHOQUINONES; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; PEPTIDYLPROLYL ISOMERASE; STEROID ISOMERASES; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77954236607     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901431     Document Type: Article

References (53)

1. Feldmann, M., F. M. Brennan, and R. N. Maini. 1996. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol. 14: 397-440.
2. Siegle, I., T. Klein, J. T. Backman, J. G. Saal, R. M. Nusing, and P. Fritz. 1998. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum. 41: 122-129.
3. Anderson, G. D., S. D. Hauser, K. L. McGarity, M. E. Bremer, P. C. Isakson, and S. A. Gregory. 1996. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J. Clin. Invest. 97: 2672-2679.
4. Myers, L. K., A. H. Kang, A. E. Postlethwaite, E. F. Rosloniec, S. G. Morham, B. V. Shlopov, S. Goorha, and L. R. Ballou. 2000. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum. 43: 2687-2693.
5. Bidgood, M. J., O. S. Jamal, A. M. Cunningham, P. M. Brooks, and K. F. Scott. 2000. Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes. J. Immunol. 165: 2790-2797.
6. Martel-Pelletier, J., J. P. Pelletier, and H. Fahmi. 2003. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin. Arthritis Rheum. 33: 155-167.
7. Lu, K. P., S. D. Hanes, and T. Hunter. 1996. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380: 544-547.
8. Bayer, E., S. Goettsch, J. W. Mueller, B. Griewel, E. Guiberman, L. M. Mayr, and P. Bayer. 2003. Structural analysis of the mitotic regulator hPin1 in solution: insights into domain architecture and substrate binding. J. Biol. Chem. 278: 26183-26193.
9. Lu, K. P. 2004. Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem. Sci. 29: 200-209.
10. Weiwad, M., G. Küllertz, M. Schutkowski, and G. Fischer. 2000. Evidence that the substrate backbone confirmation is critical to phosphorylation by p42 MAP kinase. FEBS Lett. 478: 39-42.
11. Zhou, X. Z., O. Kops, A. Werner, P. J. Lu, M. Shen, G. Stoller, G. Küllertz, M. Stark, G. Fischer, and K. P. Lu. 2000. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol. Cell 6: 873-883.
12. Bao, L., G. Sauter, J. Sowadski, K. P. Lu, and D. Wang. 2004. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. 164: 1727-1737. (Pubitemid 38529775)
13. Balastik, M., J. Lim, L. Pastorino, and K. P. Lu. 2007. Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism? Biochim. Biophys. Acta 1772: 422-429.
14. Pang, R., T. K. Lee, R. T. Poon, S. T. Fan, K. B. Wong, Y. L. Kwong, and E. Tse. 2007. Pin1 interacts with a specific serine-proline motif of hepatitis B virus Xprotein to enhance hepatocarcinogenesis. Gastroenterology 132: 1088-1103.
15. Shen, Z. J., S. Esnault, and J. S. Malter. 2005. The peptidyl-prolyl isomerase Pin1 regulates the stability of granulocyte-macrophage colony-stimulating factor mRNA in activated eosinophils. Nat. Immunol. 6: 1280-1287.
16. Shen, Z. J., S. Esnault, L. A. Rosenthal, R. J. Szakaly, R. L. Sorkness, P. R. Westmark, M. Sandor, and J. S. Malter. 2008. Pin1 regulates TGF-β1 production by activated human and murine eosinophils and contributes to allergic lung fibrosis. J. Clin. Invest. 118: 479-490.
17. Esnault, S., Z. J. Shen, E. Whitesel, and J. S. Malter. 2006. The peptidyl-prolyl isomerase Pin1 regulates granulocyte-macrophage colony-stimulating factor mRNA stability in T lymphocytes. J. Immunol. 177: 6999-7006. (Pubitemid 44715066)
18. Holmdahl, R., M. Andersson, T. J. Goldschmidt, K. Gustafsson, L. Jansson, and J. A. Mo. 1990. Type II collagen autoimmunity in animals and provocations leading to arthritis. Immunol. Rev. 118: 193-232.
19. Sekine, C., T. Sugihara, S. Miyake, H. Hirai, M. Yoshida, N. Miyasaka, and H. Kohsaka. 2008. Successful treatment of animal models of rheumatoid arthritis with small-molecule cyclin-dependent kinase inhibitors. J. Immunol. 180: 1954-1961.
20. Leng, J., H. Yao, J. Shen, K. Wang, G. Zhuo, and Z. Wang. 2008. Co-expression of IL-18 binding protein and IL-4 regulates Th1/Th2 cytokine response in murine collagen-induced arthritis. Acta Biochim. Biophys. Sin. 40: 116-124.
21. Lee, J. Y., C. Y. Han, J. W. Yang, C. Smith, S. K. Kim, E. Y. Lee, S. G. Kim, and K. W. Kang. 2007. Induction of glutathione transferase in insulin-like growth factor type I receptor-overexpressed hepatoma cells. Mol. Pharmacol. 72: 1082-1093.
22. Jeong, H. G., Y. R. Pokharel, E. H. Han, and K. W. Kang. 2007. Induction of cyclooxygenase-2 by ginsenoside Rd via activation of CCAAT-enhancer binding proteins and cyclic AMP response binding protein. Biochem. Biophys. Res. Commun. 359: 51-56.
23. Esnault, S., R. K. Braun, Z. J. Shen, Z. Xiang, E. Heninger, R. B. Love, M. Sandor, and J. S. Malter. 2007. Pin1 modulates the type 1 immune response. PLoS One 2: e226.
24. Esnault, S., L. A. Rosenthal, Z. J. Shen, J. B. Sedgwick, R. J. Szakaly, R. L. Sorkness, and J. S. Malter. 2007. A critical role for Pin1 in allergic pulmonary eosinophilia in rats. J. Allergy Clin. Immunol. 120: 1082-1088.
25. Thomas, B., F. Berenbaum, L. Humbert, H. Bian, G. Bereziat, L. Crofford, and J. L. Olivier. 2000. Critical role of C/EBP-β and C/EBP-δ factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1 in articular chondrocytes. Eur. J. Biochem. 267: 6798-6809.
26. Wardlaw, S. A., N. Zhang, and S. A. Belinsky. 2002. Transcriptional regulation of basal cyclooxygenase-2 expression in murine lung tumor-derived cell lines by CCAAT/enhancer-binding protein and activating transcription factor/cAMP response element-binding protein. Mol. Pharmacol. 62: 326-333.
27. Tamura, M., S. Sebastian, S. Yang, B. Gurates, Z. Fang, K. Okamura, and S. E. Bulun. 2003. Induction of cyclooxygenase-2 in human endometrial stromal cells by malignant endometrial epithelial cells: evidence for the involvement of extracellularly regulated kinases and CCAAT/enhancer binding proteins. J. Mol. Endocrinol. 31: 95-104.
28. Newton, R., L. M. Kuitert, M. Bergmann, I. M. Adcock, and P. J. Barnes. 1997. Evidence for involvement of NF-κB in the transcriptional control of COX-2 gene expression by IL-1β. Biochem. Biophys. Res. Commun. 237: 28-32.
29. Tak, P. P., and G. S. Firestein. 2001. NF-κB: a key role in inflammatory diseases. J. Clin. Invest. 107: 7-11.
30. Xiao, C., and S. Ghosh. 2005. NF-κB, an evolutionarily conserved mediator of immune and inflammatory responses. Adv. Exp. Med. Biol. 560: 41-55. (Pubitemid 43759173)
31. Ryo, A., F. Suizu, Y. Yoshida, K. Perrem, Y. C. Liou, G. Wulf, R. Rottapel, S. Yamaoka, and K. P. Lu. 2003. Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 12: 1413-1426.
32. Tang, Q., W. Chen, M. S. Gonzales, J. Finch, H. Inoue, and G. T. Bowden. 2001. Role of cyclic AMP responsive element in the UVB induction of cyclooxygenase-2 transcription in human keratinocytes. Oncogene 20: 5164-5172.
33. Wulf, G. M., A. Ryo, G. G. Wulf, S. W. Lee, T. Niu, V. Petkova, and K. P. Lu. 2001. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 20: 3459-3472.
34. Monje, P., J. Hernandez-Losa, R. J. Lyons, M. D. Castellone, and J. S. Gutkind. 2005. Regulation of the transcriptional activity of c-Fos by ERK: a novel role for the prolyl isomerase PIN1. J. Biol. Chem. 280: 35081-35084.
35. Xie, Q. W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269: 4705-4708.
36. Chun, K. S., and Y. J. Surh. 2004. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol. 68: 1089-1100.
37. Han, S., N. Sidell, S. Roser-Page, and J. Roman. 2004. Fibronectin stimulates human lung carcinoma cell growth by inducing cyclooxygenase-2 (COX-2) expression. Int. J. Cancer 111: 322-331.
38. Ki, S. H., M. J. Choi, C. H. Lee, and S. G. Kim. 2007. Gα12 specifically regulates COX-2 induction by sphingosine 1-phosphate: role for JNK-dependent ubiquitination and degradation of IκBα. J. Biol. Chem. 282: 1938-1947.
39. Hennig, L., C. Christner, M. Kipping, B. Schelbert, K. P. Rücknagel, S. Grabley, G. Küllertz, and G. Fischer. 1998. Selective inactivation of parvulin-like peptidyl- prolyl cis/trans isomerases by juglone. Biochemistry 37: 5953-5960.
40. Ahn, K. S., and B. B. Aggarwal. 2005. Transcription factor NF-κBa sensor for smoke and stress signals. Ann. NY Acad. Sci. 1056: 218-233.
41. Bremner, P., and M. Heinrich. 2002. Natural products as targeted modulators of the nuclear factor-κB pathway. J. Pharm. Pharmacol. 54: 453-472.
42. Kauss, T., D. Moynet, J. Rambert, A. Al-Kharrat, S. Brajot, D. Thiolat, R. Ennemany, F. Fawaz, and M. D. Mossalayi. 2008. Rutoside decreases human macrophage-derived inflammatory mediators and improves clinical signs in adjuvant- induced arthritis. Arthritis Res. Ther. 10: R19.
43. Dlaska, M., and G. Weiss. 1999. Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J. Immunol. 162: 6171-6177. (Pubitemid 29314979)
44. Kinugawa, K., T. Shimizu, A. Yao, O. Kohmoto, T. Serizawa, and T. Takahashi. 1997. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ. Res. 81: 911-921. (Pubitemid 27514940)
45. Miller, M. 2006. Phospho-dependent protein recognition motifs contained in C/EBP family of transcription factors: in silico studies. Cell Cycle 5: 2501-2508.
46. Pang, R. W., T. K. Lee, K. Man, R. T. Poon, S. T. Fan, Y. L. Kwong, and E. Tse. 2006. PIN1 expression contributes to hepatic carcinogenesis. J. Pathol. 210: 19-25.
47. Takahashi, K., C. Uchida, R. W. Shin, K. Shimazaki, and T. Uchida. 2008. Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease. Cell. Mol. Life Sci. 65: 359-375.
48. Furst, D. E. 1996. Clinical pharmacology of combination DMARD therapy in rheumatoid arthritis. J. Rheumatol. 44: 86-90. (Pubitemid 26094653)
49. Dourlen, P., K. Ando, M. Hamdane, S. Begard, L. Buée, and M. C. Galas. 2007. The peptidyl prolyl cis/trans isomerase Pin1 down-regulates the inhibitor of apoptosis protein survivin. Biochim. Biophys. Acta 1773: 1428-1437.
50. Gianni, M., A. Boldetti, V. Guarnaccia, A. Rambaldi, E. Parrella, I. Raska, Jr., C. Rochette-Egly, G. Del Sal, A. Rustighi, M. Terao, and E. Garattini. 2009. Inhibition of the peptidyl-prolyl-isomerase Pin1 enhances the responses of acute myeloid leukemia cells to retinoic acid via stabilization of RARα and PML-RARα. Cancer Res. 69: 1016-1026.
51. Zhang, Y., S. Fussel, U. Reimer, M. Schutkowski, and G. Fischer. 2002. Substrate-based design of reversible Pin1 inhibitors. Biochemistry 41: 11868-11877.
52. Wang, X. J., B. Xu, A. B. Mullins, F. K. Neiler, and F. A. Etzkorn. 2004. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere. J. Am. Chem. Soc. 126: 15533-15542.
53. Fila, C., C. Metz, and P. van der Sluijs. 2008. Juglone inactivates cysteine-rich proteins required for progression through mitosis. J. Biol. Chem. 283: 21714-21724.